瘤微环境刺激-响应线性-状聚合物合物作为潜在的纳米医学
Yongchao Wang1, Pan Xiang1, Yinggang Li1
1Department of Radiology, Institution of Radiology and Medical Imaging, Huaxi MR Research Center (HMRRC), Department of Thoracic Surgery and Institute of Thoracic Oncology, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, China.
Macromolecular rapid communications
|March 16, 2026
概括
一种新的线性状聚合物纳米颗粒有效地提供多克索鲁比 (DOX) 用于癌症治疗. 这种对瘤有反应的纳米药物增强了瘤部位的药物积累,同时减少了副作用.
科学领域:
- 聚合物化学 聚合物化学
- 纳米医学是一种纳米医学.
- 药物输送系统 药物输送系统
背景情况:
- 开发先进的药物输送系统对于有效的癌症治疗至关重要.
- 瘤微环境响应材料提供有针对性的药物释放,最大限度地减少全身毒性.
- 线性状聚合物为纳米载体设计提供了独特的架构.
研究的目的:
- 为了合成和表征一个瘤微环境响应,线性-状聚合物-多克索鲁比结合物.
- 评估开发的纳米药物的自我组装,药物释放动力学和体外/体内抗癌疗效.
- 在临床前癌症模型中评估纳米药物的安全性.
主要方法:
- 采用两步可逆添加-碎片化链转移 (RAFT) 聚合,合成基于聚[N-(2-基) 甲基胺] (polyHPMA) 的共聚合物-多克索鲁结合物 (pHPMA-块-pDendron-DOX).
- 结合物自组装成纳米粒子 (NP),其中包含一种可以切割瘤的Gly-Phe-Leu-Gly (GFLG) 和一种pH敏感的链.
- 使用4T1细胞进行了体外细胞毒性测定,并在4T1小鼠乳腺癌异种移植模型中进行了体内研究.
主要成果:
- 合成的pHPMA-block-pDendron-DOX结合物形成了稳定的纳米粒子,这些纳米粒子表现出甲素B和pH响应的药物释放.
- 通过内分细胞形成途径的内化导致了对4T1癌细胞显著的细胞毒性作用.
- 在体内观察到瘤部位增加多克索鲁比辛积累和有前途的抗癌作用,副作用显著减少.
结论:
- 线性-树突性聚合物结合物成功地自我组装成对瘤有反应的纳米药物,用于向的多克索鲁比输送.
- 开发的纳米药物表现出强大的抗癌活性和改善的安全性,突出其作为有效和安全的治疗剂的潜力.
相关概念视频
Site-Targeted Drug Delivery Systems: Polymeric Carriers
82
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
82
The Tumor Microenvironment
8.0K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.0K
The Tumor Microenvironment
3.0K
3.0K
Modified-Release Drug Delivery Systems: Site-Targeted
71
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
71
Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K


